Association of blood eosinophils and plasma periostin with FEV₁ response after 3-month inhaled corticosteroid and long-acting beta₂-agonist treatment in stable COPD patients

References

• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease2015 [cited March 1, 2015]. Available from: www.goldcopd.org
   Google Scholar
• LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
   PubMed Web of Science ®Google Scholar
• PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990425210450
   PubMed Web of Science ®Google Scholar
• VestboJVogelmeierCSmallMHigginsVUnderstanding the GOLD 2011 strategy as applied to a real-world COPD populationRespir Med2014108572973624675239
   PubMed Web of Science ®Google Scholar
• LapperreTSSnoeck-StrobandJBGosmanMMEffect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trialAnn Intern Med2009151851752719841453
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CatalunaJJCalleMSorianoJBTreatment of COPD by clinical phenotypes: putting old evidence into clinical practiceEur Respir J20134161252125623060631
   PubMed Web of Science ®Google Scholar
• BarnesPJMediators of chronic obstructive pulmonary diseasePharmacol Rev200456451554815602009
   PubMed Web of Science ®Google Scholar
• ChristensonSASteilingKvan den BergeMAsthma-COPD overlapClinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2015191775876625611785
   PubMed Web of Science ®Google Scholar
• SahaSBrightlingCEEosinophilic airway inflammation in COPDInt J Chron Obstruct Pulmon Dis200611394718046901
   PubMedGoogle Scholar
• PapiARomagnoliMBaraldoSPartial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016251773177711069811
   PubMed Web of Science ®Google Scholar
• BrightlingCEMcKennaSHargadonBSputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary diseaseThorax200560319319815741434
   PubMed Web of Science ®Google Scholar
• WagenerAHde NijsSBLutterRExternal validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthmaThorax201570211512025422384
   PubMed Web of Science ®Google Scholar
• JiaGEricksonRWChoyDFPeriostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patientsJ Allergy Clin Immunol20121303647654.e1022857879
   PubMed Web of Science ®Google Scholar
• ParkTSLeeJSSeoJBStudy design and outcomes of Korean obstructive lung disease (KOLD) cohort StudyTuberc Respir Dis (Seoul)201476416917424851130
   PubMedGoogle Scholar
• Standardization of spirometry, 1994 update. American Thoracic SocietyAm J Respir Crit Care Med19951523110711367663792
   PubMed Web of Science ®Google Scholar
• ChoiJKPaekDLeeJONormal predictive values of spirometry in Korean populationTuberc Respir Dis (Seoul)2005583230242
   Google Scholar
• PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
   PubMed Web of Science ®Google Scholar
• BewickVCheekLBallJStatistics review 13: receiver operating characteristic curvesCrit Care20048650851215566624
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
   PubMed Web of Science ®Google Scholar
• BarnesPJThe cytokine network in asthma and chronic obstructive pulmonary diseaseJ Clin Invest2008118113546355618982161
   PubMed Web of Science ®Google Scholar
• PanznerPLafitteJJTsicopoulosAHamidQTulicMKMarked up-regulation of T lymphocytes and expression of interleukin-9 in bronchial biopsies from patients With chronic bronchitis with obstructionChest200312451909191514605067
   PubMed Web of Science ®Google Scholar
• RiiseGCAhlstedtSLarssonSBronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluidThorax19955043603657785007
   PubMed Web of Science ®Google Scholar
• TakayamaGArimaKKanajiTPeriostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signalsJ Allergy Clin Immunol200611819810416815144
   PubMed Web of Science ®Google Scholar
• Wills-KarpMLuyimbaziJXuXInterleukin-13: central mediator of allergic asthmaScience19982825397225822619856949
   PubMed Web of Science ®Google Scholar
• GrunigGWarnockMWakilAERequirement for IL-13 independently of IL-4 in experimental asthmaScience19982825397226122639856950
   PubMed Web of Science ®Google Scholar
• WoodruffPGBousheyHADolganovGMGenome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroidsProc Natl Acad Sci U S A200710440158581586317898169
   PubMed Web of Science ®Google Scholar
• CorrenJLemanskeRFHananiaNALebrikizumab treatment in adults with asthmaN Engl J Med2011365121088109821812663
   PubMed Web of Science ®Google Scholar
• KitaguchiYFujimotoKKuboKHondaTCharacteristics of COPD phenotypes classified according to the findings of HRCTRespir Med2006100101742175216549342
   PubMed Web of Science ®Google Scholar
• BoschettoPMiniatiMMiottoDPredominant emphysema phenotype in chronic obstructive pulmonaryEur Respir J200321345045412662000
   PubMed Web of Science ®Google Scholar
• MakitaHNasuharaYNagaiKCharacterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary diseaseThorax2007621193293717573447
   PubMed Web of Science ®Google Scholar
• CazzolaMMacNeeWMartinezFJOutcomes for COPD pharmacological trials: from lung function to biomarkersEur Respir J200831241646918238951
   PubMed Web of Science ®Google Scholar
• BatemanEDFergusonGTBarnesNDual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE studyEur Respir J20134261484149423722616
   PubMed Web of Science ®Google Scholar